YFY Group

YFY Group is a prominent Taiwanese conglomerate that has evolved from its roots in paper and packaging into a major force in the global biotechnology and healthcare sectors. Through its strategic investment arm, YFY Biotech Management, the group has founded and nurtured several leading life science companies, including TaiMed Biologics and EirGenix. The group's portfolio covers a wide range of activities, from the development of novel biologics for infectious diseases to the manufacturing of biosimilars and contract development services. YFY Group plays a critical role in the Asian biotech ecosystem, providing capital, infrastructure, and management expertise to advance innovative therapies. Its most notable successes include the commercialization of Trogarzo, the first long-acting monoclonal antibody for multi-drug resistant HIV, developed by its subsidiary TaiMed Biologics.